Cukurova Univ. Tip. Fak. Balcali Hastanesi

Adana 01790

2 studies enrolling now · 3 studies all time

What they study most

Children, Chronic Kidney Disease, Proteinuria, Scleroderma, Systemic

Studies at this site

• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria — Recruiting now
• A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria — Recruiting now
• Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis — Completed